In this issue:
Chronic rhinosinusitis with nasal polyps guidance and biologic integration
British thyroid nodule and endocrine surgery consensus update
ENT quality measurement and practice benchmarking updates
Emerging “living guideline” models in otolaryngology
FDA approval of dupilumab for allergic fungal rhinosinusitis
First FDA-approved gene therapy for inherited hearing loss
European Commission approves depemokimab for CRSwNP
Australian biologic access developments for chronic rhinosinusitis
New Zealand biologic funding considerations for CRSwNP
New Zealand Society of Otolaryngology scientific meeting preparations
ASOHNS international scholarship applications opened for 2026
Increased emphasis on temporal bone and advanced surgical simulation training
Conferences, Workshops, CPD
Research Review Publications
Please login below to download this issue (PDF)